Acadia Pharmaceuticals Inc
- Last sale
- Nov 6, 2026 · +0.00%
- Market cap
- $3.67B
- 172.83M shares
- Filings
- 1,015
Q3 2026+11.9% FY25 yoy
Q3 2026+72.7% FY25 yoy
Q3 2026−54.6% FY25 yoy
Q3 2026derived−33.1% FY25 yoy
Q3 2026+69.1% FY25 yoy
Q3 2026−44.4% FY25 yoy
- $3.67B
- 10.1×
- 3.0×
- 2.6×
- 2.24%
- —
Twelve months to Sep 30, 2026 · derived
Price
Nov 6, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $1,071,505,000 | reported | |
| FY 2024 | 2024-12-31 | $957,797,000 | reported | |
| FY 2023 | 2023-12-31 | $726,437,000 | reported | |
| FY 2022 | 2022-12-31 | $517,235,000 | reported | |
| FY 2021 | 2021-12-31 | $484,145,000 | reported | |
| FY 2020 | 2020-12-31 | $441,755,000 | reported | |
| FY 2019 | 2019-12-31 | $339,076,000 | reported | |
| FY 2018 | 2018-12-31 | $223,807,000 | reported | |
| FY 2017 | 2017-12-31 | $124,901,000 | reported | |
| FY 2016 | 2016-12-31 | $17,331,000 | reported | |
| FY 2015 | 2015-12-31 | $61,000 | reported | |
| FY 2014 | 2014-12-31 | $120,000 | reported |
Pharmaceutical preparations
Acadia Pharmaceuticals Inc is the 34th largest of the 554 covered companies the SEC files under this code, by revenue. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
SUPNSupernus, Inc.$1.2B4.3%16.9%$3.4BNSRXNasus Pharma Ltd$1.2B—0.5%$26.6MPBHPrestige Consumer Healthcare Inc.$1.1B4.3%17.5%$2.1B
ACADAcadia Pharmaceuticals Inc (this company)$1.1B11.9%36.5%$3.7B
LEGNLegend Biotech Corp$1.0B64.0%28.8%$3.4BMDGLMadrigal Pharmaceuticals, Inc.$958.4M432.1%30.1%$9.9BIONSIonis Pharmaceuticals Inc$943.7M33.8%40.4%$4.5BANIPANI Pharmaceuticals Inc$883.4M43.8%8.9%$1.6BHRMYHarmony Biosciences Holdings, Inc.$868.5M21.5%18.3%$2.0BPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Acadia Pharmaceuticals Inc · CIK 1070494 · Engraved from SEC EDGAR